Get started
Author

Dalma Hosszú

Observed names: D Hosszú, D. Hosszú, Dalma Hosszu, Hosszú Dalma, Hosszú, Dalma
ORCID: 0009-0004-5835-2516
Observed ORCID: 0009-0004-5835-2516
OpenAlex ID: A5051102784
Parent-child agreement on health-related quality of life: the role of perceived consequences of the child’s chronic illness
2022 · Zsuzsanna Katalin Papp, Szabolcs Török, et al. · Psychology and Health · 9
Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study
2024 · Dalma Hosszú, Alexandra L. Dima, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 6
The eyes of the beholder: Perceived barriers to successful drug repurposing
2025 · Zsuzsanna Ida Petykó, Dalma Hosszú, et al. · British Journal of Pharmacology · 4
PDF
Short- and longer-term goals for change – A report from the 2nd workshops of the EHC Think Tank Workstreams on Access Equity and Future Care Pathways
2023 · Zita Gacser, Naja Skouw-Rasmussen, et al. · The Journal of Haemophilia Practice · 2
Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges
2026 · Kristóf Gyöngyösi, Zsuzsanna Ida Petykó, et al. · Health Policy OPEN · 1
P51 Catalogue of Actions to Address Policy Barriers of Drug Repurposing
2025 · Andras Inotai, Dalma Hosszú, et al. · Value in Health · 1
Methodological study protocol for The European Atlas of clinical trials in cancer and haematology
2025 · Mercè Cases, Rachel Giles, et al. · Frontiers in Pharmacology · 1
PDF
2309P European atlas on clinical trials in cancer and haematology (EuroACT): Mapping research and equity across Europe
2025 · L. Puga, M. Cases Escute, et al. · Annals of Oncology · 1
HPR155 Drug Repurposing: Policy Barriers to Using Existing Pharmaceuticals in New Indications: Results of a Systematic Literature Review
2024 · Z Petykó, D Hosszú, et al. · Value in Health · 1
System change in practice: A report from the EHC Think Tank workstreams on Access Equity and Future Care Pathways
2024 · Zita Gacser, Steven Bourke, et al. · The Journal of Haemophilia Practice · 1
Egészséggel összefüggő életminőség három gyermekkori krónikus betegségben
2016 · Papp Zsuzsanna, Kökönyei Gyöngyi, et al. · Alkalmazott Pszichológia · 1
Defining a comprehensive set of value assessment criteria for funders of drug repurposing initiatives
2026 · Dalma Hosszú, Kristóf Gyöngyösi, et al. · British Journal of Clinical Pharmacology
PDF
Perceived impact and actionability of barriers to drug repurposing: Insights from a multi-stakeholder policy survey
2026 · Kristóf Gyöngyösi, Zsuzsanna Ida Petykó, et al.
Pcr101 Caregiver-defined Unmet Needs to Support Patient-centered Trial Design and Value Considerations in Multiple Sulfatase Deficiency (msd)
2026 · Dalma Hosszú, Eve Hewitt, et al. · Value in Health
Variation in use of PROMs and geographical distribution in clinical trials of selected hematological diseases in Europe
2026 · Mercè Cases, Attila Imre, et al. · Blood Global Hematology
From Pain to Patient Preferences: Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta
2026 · Dalma Hosszú, Eve Hewitt, et al.
PDF
Unlocking drug repurposing potential: Dutch multi-stakeholder perspectives on policy mechanisms
2026 · Menke Winckers, Kristóf Gyöngyösi, et al.
PDF
Incorporating cost considerations into shared decision-making: A cross-country comparison among Hungary, France, and Bulgaria
2026 · Guenka Petrova, Maria Kamusheva, et al. · Pharmacia
PDF
Perceived impact and actionability of barriers to drug repurposing: Insights from a multi-stakeholder policy survey
2026 · Kristóf Gyöngyösi, Zsuzsanna Ida Petykó, et al.
Social framework to judge the importance of breast cancer
2025 · Zsuzsa Réka Pozsár, Krisztina Tóth, et al. · Journal of Cancer Policy
PCR100 From Pain to Patient Preferences Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta
2025 · Dalma Hosszú, Eve Hewitt, et al. · Value in Health
HPR158 Perceived Impact and Actionability of Barriers to Drug Repurposing: Insights From a Multistakeholder Policy Survey
2025 · Kristóf Gyöngyösi, Zsuzsanna Ida Petykó, et al. · Value in Health
Correction: Methodological study protocol for the European Atlas of clinical trials in cancer and haematology
2025 · Mercè Cases, Rachel Giles, et al. · Frontiers in Pharmacology
PDF
A magyarországi betegszervezetek fogalmának és lehetséges feladatainak meghatározása
2025 · Mátyás Murányi, Dalma Hosszú, et al. · Orvosi Hetilap
P36 Comparative Analysis of Large Language Models for Extracting Patient-Reported Outcome Measures From Clinical Trial Protocols in Lymphoma
2025 · Attila Imre, Dalma Hosszú, et al. · Value in Health
Works count: 32
Citation count: 28
H-index: 3
I10-index:
Year
Topic
Type